Brian Cummings, UCI professor of physical medicine & rehabilitation and founding member of the Sue & Bill Gross Stem Cell Research Center, has received a five-year, $2.7 million grant from the California Institute for Regenerative Medicine to establish a training program that supports first-generation and underserved students pursuing careers in public health and regenerative medicine. […]
Amount is second-highest ever, reflecting strong support for campus mission
Inspired by a ruby beam of light, the Beckman Laser Institute co-founder changed science, medicine – and UCI
At White House event, Howard Gillman discusses challenges facing U.S. universities in wake of Roe v. Wade overturn
The multidisciplinary team will focus on participant recruitment and retainment for Alzheimer’s disease and related disorders research
Findings will advance development of better early diagnostic tools, new treatment strategies
Mathematician Svetlana Jitomirskaya, vision researcher Krzysztof Palczewski honored
Marquis Vawter, Ph.D., research professor in the Department of Psychiatry & Human Behavior at the UCI School of Medicine, participated in companion studies published in Nature, analyzing regions of the human genome associated with increased risk of schizophrenia. Researchers knew that the disorder carries a 60 to 80 percent inheritability and wanted to determine common […]
Selma Masri, assistant professor of biological chemistry in the UCI School of Medicine, has won the prestigious 2022 Johnson & Johnson WiSTEM2D Scholars Award for Science. The awards program honors one scholar in each STEM2D discipline: science, technology, engineering, math, manufacturing and design. The six diverse, international female recipients were selected out of a competitive […]
Nick Pannunzio, Ph.D., assistant professor of medicine in the Division of Hematology/Oncology at the UCI School of Medicine, has received a Method to Extend Research in Time Award from the National Cancer Institute. The seven-year grant will bring approximately $410,000 annually to fund his study into a particular acute lymphoblastic leukemia subtype called Philadelphia chromosome-like […]